AtriCure (ATRC) Gains from Investment Securities (2014 - 2021)

AtriCure (ATRC) has reported Gains from Investment Securities for 6 consecutive years, with $184.8 million the latest figure, recorded in Q3 2021.

• In Q3 2021, Gains from Investment Securities rose 96150.0% year-over-year to $184.8 million; the TTM figure through Jun 2022 stood at $184.8 million (up 1787.83% YoY), while the FY2021 annual figure was -$184.8 million, down 51664.71% from the prior year.
• Gains from Investment Securities improved to $184.8 million in Q3 2021 per ATRC's latest filing, from $2.6 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $184.8 million in Q3 2021 and bottomed at -$7.5 million in Q2 2020.
• Historically, Gains from Investment Securities has averaged $13.8 million across 4 years, with a median of $192000.0 in 2020.
• Annual changes were most pronounced in 2019 — Gains from Investment Securities slumped 292.56% — and 2021, when it jumped 96150.0%.
• AtriCure's Gains from Investment Securities stood at -$4.1 million in 2018, then jumped by 148.87% to $2.0 million in 2019, then surged by 122.84% to $4.5 million in 2020, then surged by 4009.41% to $184.8 million in 2021.
• Business Quant data shows ATRC's Gains from Investment Securities at $184.8 million in Q3 2021, $2.6 million in Q2 2021, and $2.5 million in Q1 2021.